Homology Medicines, Inc. (FIXX) financial statements (2022 and earlier)

Company profile

Business Address ONE PATRIOTS PARK
BEDFORD, MA 01730
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments155,873217,431262,388214,737
Cash and cash equivalents108,382217,43153,77438,220
Short-term investments47,491 208,614176,517
Other undisclosed current assets36,0362,1334,1896,948
Total current assets:191,909219,564266,577221,685
Noncurrent Assets
Operating lease, right-of-use asset15,6075,897 
Property, plant and equipment2,25237,00242,71635,637
Other undisclosed noncurrent assets1,9531,2741,2741,772
Total noncurrent assets:19,81244,17343,99037,409
TOTAL ASSETS:211,721263,737310,567259,094
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,57912,1197,95719,601
Accounts payable2,3664,7222,60815,732
Accrued liabilities1,408495798499
Employee-related liabilities7,8056,9024,5513,370
Deferred revenue3,2085,632809
Deferred rent credit  1,313977
Other undisclosed current liabilities2,4394,9072,2954,855
Total current liabilities:17,22622,65812,37425,433
Noncurrent Liabilities
Long-term debt and lease obligation23,68812,941  
Operating lease, liability23,68812,941 
Liabilities, other than long-term debt1,15632,14339,6869,470
Deferred revenue1,15632,14330,142
Deferred rent credit  9,5449,470
Other undisclosed noncurrent liabilities   29,474
Total noncurrent liabilities:24,84445,08439,68638,944
Total liabilities:42,07067,74252,06064,377
Stockholders' equity
Stockholders' equity attributable to parent169,651195,995258,507194,717
Common stock6543
Additional paid in capital593,784524,358457,994292,187
Accumulated other comprehensive income (loss)(7) 183(77)
Accumulated deficit(424,132)(328,368)(199,674)(97,396)
Total stockholders' equity:169,651195,995258,507194,717
TOTAL LIABILITIES AND EQUITY:211,721263,737310,567259,094

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues33,9712,7021,6663,684
Amortization of lease incentives6,320   
Sublease income861913 
Gross profit:33,9712,7021,6663,684
Operating expenses(129,920)(132,965)(111,609)(65,248)
Operating loss:(95,949)(130,263)(109,943)(61,564)
Nonoperating income3703,1386,0274,349
Investment income, nonoperating1851,569  
Other nonoperating income1851,5696,0274,349
Loss before gain (loss) on sale of properties:(95,579)(127,125)(103,916)(57,215)
Other undisclosed net loss(185)(1,569)  
Net loss available to common stockholders, diluted:(95,764)(128,694)(103,916)(57,215)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(95,764)(128,694)(103,916)(57,215)
Comprehensive loss:(95,764)(128,694)(103,916)(57,215)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(7)(183)260(4)
Comprehensive loss, net of tax, attributable to parent:(95,771)(128,877)(103,656)(57,219)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: